The in vitro diagnostics industry occupies a uniquely complex position in the healthcare supply chain. IVD companies don't just sell a product—they sell a laboratory testing capability that their customers must be licensed to operate, trained to run, validated to clinical standards, supplied with consumables on a continuous basis, and maintained in ongoing compliance with proficiency testing programs. Each of these requirements generates a distinct stream of administrative coordination that IVD commercial and field teams are ill-equipped to absorb alongside their primary technical and sales responsibilities.
The U.S. IVD market reached $38 billion in 2023 according to the American Clinical Laboratory Association (ACLA), with point-of-care diagnostics—where CLIA waiver requirements are most prominent—among the fastest-growing segments. As IVD companies scale their point-of-care and near-patient testing platforms, the administrative burden of customer compliance support scales with them.
CLIA Waiver Documentation Management
IVD tests categorized as CLIA-waived can be performed by physician offices, urgent care centers, pharmacies, and other non-laboratory settings—but only after the facility obtains a Certificate of Waiver from CMS. The waiver application process requires the facility to complete CMS Form 116, pay the applicable fee, and designate a laboratory director.
Many IVD customers—particularly small physician offices—need guidance and administrative support through this process. The VA manages CLIA waiver application support for the IVD company's new customers: providing the Form 116 completion checklist, tracking application submission and approval status, following up with CMS on pending applications, and confirming waiver receipt before the customer's first patient test.
Laboratory Customer Onboarding Coordination
When a new laboratory account is established, onboarding involves multiple parallel workstreams: instrument installation and qualification, laboratory personnel training scheduling, analytical validation protocol coordination, quality control setup, and reagent account activation. The VA project-manages the onboarding checklist for each new account—coordinating between the field application specialist, the laboratory customer's staff, and the IVD company's logistics team to ensure each onboarding milestone is completed on schedule.
Poor onboarding completion is the leading cause of first-year customer churn in the IVD industry, according to a 2023 J2 Global diagnostics industry analysis. VA-managed onboarding coordination directly reduces this risk.
Reagent Supply Chain Tracking
IVD platforms require a continuous supply of matched reagents, calibrators, and controls. Customers with irregular ordering patterns run out of reagents mid-shift—causing patient care disruptions and opening the door for competitive displacement. The VA monitors customer reagent consumption rates against par level thresholds, generates proactive replenishment alerts, coordinates with the distribution team on expedited orders when needed, and tracks lot number and expiration date records for the account's quality files.
Proficiency Testing Documentation
CLIA regulations require that laboratories participate in approved proficiency testing (PT) programs and achieve satisfactory performance on a defined schedule. For the IVD company, supporting customer PT compliance is a retention and compliance risk management function. The VA tracks each customer's PT enrollment status, monitors for PT results notifications, flags unsatisfactory PT performance for the field application specialist's follow-up, and maintains the PT documentation file for each account.
Find IVD laboratory coordination VA support at Stealth Agents to keep your customer compliance programs running and reduce first-year churn.
Sources
- American Clinical Laboratory Association (ACLA) IVD Market Analysis, 2023
- CMS Clinical Laboratory Improvement Amendments (CLIA) Program Overview, 2024
- Clinical Laboratory Improvement Advisory Committee (CLIAC) Meeting Summary, 2023
- J2 Global Diagnostics Industry Customer Retention Analysis, 2023
- CMS Form 116 CLIA Application for Certificate of Waiver, 2024